BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33128352)

  • 1. Molecular docking-assisted screening reveals tannic acid as a natural protein disulphide isomerase inhibitor with antiplatelet and antithrombotic activities.
    Ren L; You T; Li Q; Chen G; Liu Z; Zhao X; Wang Y; Wang L; Wu Y; Tang C; Zhu L
    J Cell Mol Med; 2020 Dec; 24(24):14257-14269. PubMed ID: 33128352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPW-RX40 prevents human platelet activation by attenuating cell surface protein disulfide isomerases.
    Kung PH; Hsieh PW; Lin YT; Lee JH; Chen IH; Wu CC
    Redox Biol; 2017 Oct; 13():266-277. PubMed ID: 28600983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A humanized monoclonal antibody that inhibits platelet-surface ERp72 reveals a role for ERp72 in thrombosis.
    Holbrook LM; Sandhar GK; Sasikumar P; Schenk MP; Stainer AR; Sahli KA; Flora GD; Bicknell AB; Gibbins JM
    J Thromb Haemost; 2018 Feb; 16(2):367-377. PubMed ID: 29052936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome.
    Fan GQ; Qin RR; Li YH; Song DJ; Chen TS; Zhang W; Zhong M; Zhang Y; Xing YQ; Wang ZH
    Oncotarget; 2016 Dec; 7(50):83231-83240. PubMed ID: 27825126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antiplatelet role for a protein disulfide isomerase-targeted peptide: evidence of covalent binding to the C-terminal CGHC redox motif.
    Sousa HR; Gaspar RS; Sena EM; da Silva SA; Fontelles JL; AraUjo TL; Mastrogiovanni M; Fries DM; Azevedo-Santos AP; Laurindo FR; Trostchansky A; Paes AM
    J Thromb Haemost; 2017 Apr; 15(4):774-784. PubMed ID: 28109047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein disulphide isomerase in platelet function.
    Manickam N; Sun X; Li M; Gazitt Y; Essex DW
    Br J Haematol; 2008 Jan; 140(2):223-9. PubMed ID: 18028487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial microparticle-associated protein disulfide isomerase increases platelet activation in diabetic coronary heart disease.
    Sun XD; Han L; Lan HT; Qin RR; Song M; Zhang W; Zhong M; Wang ZH
    Aging (Albany NY); 2021 Jul; 13(14):18718-18739. PubMed ID: 34285139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juglone prevents human platelet aggregation through inhibiting Akt and protein disulfide isomerase.
    Kao CC; Kung PH; Tai CJ; Tsai MC; Cheng YB; Wu CC
    Phytomedicine; 2021 Feb; 82():153449. PubMed ID: 33387969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-targeting thiol reduction sensor detects thiol isomerase activity on activated platelets in mouse and human blood under flow.
    Zhu S; Welsh JD; Brass LF; Diamond SL
    J Thromb Haemost; 2016 May; 14(5):1070-81. PubMed ID: 26725377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.
    Lei X; Reheman A; Hou Y; Zhou H; Wang Y; Marshall AH; Liang C; Dai X; Li BX; Vanhoorelbeke K; Ni H
    Thromb Haemost; 2014 Feb; 111(2):279-89. PubMed ID: 24172860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet protein disulfide isomerase is required for thrombus formation but not for hemostasis in mice.
    Kim K; Hahm E; Li J; Holbrook LM; Sasikumar P; Stanley RG; Ushio-Fukai M; Gibbins JM; Cho J
    Blood; 2013 Aug; 122(6):1052-61. PubMed ID: 23788140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel anti-thrombotic agent for modulation of protein disulfide isomerase family member ERp57 for prophylactic therapy.
    Cui G; Shan L; Guo L; Chu IK; Li G; Quan Q; Zhao Y; Chong CM; Zhang Z; Yu P; Hoi MP; Sun Y; Wang Y; Lee SM
    Sci Rep; 2015 Jun; 5():10353. PubMed ID: 26037049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein disulfide isomerase inhibitors constitute a new class of antithrombotic agents.
    Jasuja R; Passam FH; Kennedy DR; Kim SH; van Hessem L; Lin L; Bowley SR; Joshi SS; Dilks JR; Furie B; Furie BC; Flaumenhaft R
    J Clin Invest; 2012 Jun; 122(6):2104-13. PubMed ID: 22565308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The integrin PSI domain has an endogenous thiol isomerase function and is a novel target for antiplatelet therapy.
    Zhu G; Zhang Q; Reddy EC; Carrim N; Chen Y; Xu XR; Xu M; Wang Y; Hou Y; Ma L; Li Y; Rui M; Petruzziello-Pellegrini TN; Lavalle C; Stratton TW; Lei X; Adili R; Chen P; Zhu C; Wilkins JA; Hynes RO; Freedman J; Ni H
    Blood; 2017 Mar; 129(13):1840-1854. PubMed ID: 28122739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The b' domain of protein disulfide isomerase cooperates with the a and a' domains to functionally interact with platelets.
    Wang L; Zhou J; Wang L; Wang CC; Essex DW
    J Thromb Haemost; 2019 Feb; 17(2):371-382. PubMed ID: 30566278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein disulphide isomerase mediates platelet aggregation and secretion.
    Essex DW; Li M
    Br J Haematol; 1999 Mar; 104(3):448-54. PubMed ID: 10086777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein disulfide isomerase regulation by nitric oxide maintains vascular quiescence and controls thrombus formation.
    Bekendam RH; Iyu D; Passam F; Stopa JD; De Ceunynck K; Muse O; Bendapudi PK; Garnier CL; Gopal S; Crescence L; Chiu J; Furie B; Panicot-Dubois L; Hogg PJ; Dubois C; Flaumenhaft R
    J Thromb Haemost; 2018 Nov; 16(11):2322-2335. PubMed ID: 30207066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacitracin reveals a role for multiple thiol isomerases in platelet function.
    Robinson A; O'Neill S; Kiernan A; O'Donoghue N; Moran N
    Br J Haematol; 2006 Feb; 132(3):339-48. PubMed ID: 16409299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
    Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
    Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.